In the context of the development of the regional Suisse Romande Réseau d’Oncologie (SRO), a privileged link is being established with the University Hospital of Geneva (HUG, Hôpital Universitaire de Genève) and the University of Geneva (UNIGE).
Spearheaded by the Department of Oncology at UNIL-CHUV and the Center of Oncology at the HUG, the two hospitals are entering in a collaborative agreement aiming to create an integrated program of medical oncology in the Lake Geneva area. This is paralleled by a collaborative agreement in progress between the Radiation Oncology services of the two hospitals.
This initiative will seek to maximize coordination and harmonization of clinical practices between CHUV and HUG in medical oncology; integrate clinical oncology research between HUG and CHUV; and maximize integration of HUG Oncology research groups in the SCC.
CHUV and HUG oncology share a common vision, and together employ over 50 oncologists and over 400 researchers. The two clinical programs combined see more than 2000 new patients and manage more than 50,000 consultations per year. Together they can extend the best treatments to patients within the Lake Geneva region, while maximizing opportunities for world-class clinical and translational research.
Université de Genève (UNIGE)
UNIGE is ranked among the 150 best universities worldwide. UNIGE research strengths in life sciences are in genetics, molecular and chemical biology, bioinformatics, and UNIGE is one of the Swiss leaders for hosting National Centres of Competence in Research (NCCR) which are main instruments of supporting important reserarch areas by the Swiss National Science Foundation. Since 2001, 8 NCCRs have been hosted by the UNIGE as leading or co-leading house including the NCCR "Frontiers in Genetics" and "Chemical Biology". In cooperation with the Geneva University Hospitals (HUG), there are over 250 research groups in basic biology and medical research showing a major translational research capacity.
The SIB Swiss Institute of Bioinformatics (SIB) is an academic, non-profit foundation recognized of public utility and established in 1998; it is organized as a federation of bioinformatics research groups from leading Swiss universities and the Swiss Federal Institutes of Technology (EPFL and EPFZ).
SIB coordinates research and education in bioinformatics throughout Switzerland and provides high quality bioinformatics services to the national and international research community.
Its 45 world-class research and service groups are currently active in the fields of: proteomics, transcriptomics, genomics, systems biology, structural bioinformatics, evolutionary bioinformatics, modeling, imaging, biophysics, population genetics and clinical bioinformatics in Basel, Bern, Fribourg, Geneva, Lausanne, Lugano and Zurich. Its expertise is widely appreciated and its services, software tools and databases are used worldwide by researchers in life sciences. Specifically, the SIB has a long-standing tradition of producing state-of-the-art software for the life science research community, as well as carefully annotated databases including UniProtKB / Swiss-Prot, the world’s most widely used source of information about proteins.
Several members of SIB are members of the SCC, their experience and knowledge enhancing the potential of the SCC research activities. The CHUV which is the SCC’s clinical platform is one of the SBI’s two partners, along with BioAlps (the Lake Geneva biocluster).